Addressing The Backlog: Government Shutdown Ends, Now FDA Has To Catch Up
This article was originally published in The Gray Sheet
Executive Summary
After the two-week shutdown, FDA staff are facing a backlog of fiscal year 2014 device submissions. The agency says it is working on a plan and assessing its ability to meet its MDUFA III commitments. The bigger concern, however, may be the regulatory uncertainty created by the short-term deal in Congress.
You may also be interested in...
FDA Shutdown Plans For 2015: Same As 2013, But With More People
Congress averted a government shutdown Oct. 1 by passing a short-term funding measure just before the deadline. But the threat of a shutdown looms once the funding expires on Dec. 11. If a shutdown occurred, "limited activities related to user fee funded programs" would continue, according to HHS' contingency plan.
The Year In Review: Device Trends To Watch In 2014
To stave off the sluggish growth in established markets, multinational medtechs not only are finding new business in countries with booming health care industries, but they’re also forging new ways to serve customers. Device companies now are pushing into services, such as disease management, and angling to compete more aggressively on pricing.
Medtech 2013: Device Companies Go Where The Growth Is
To stave off the sluggish growth in established markets, multinational medtechs not only are finding new business in countries with booming health care industries but they’re also forging new ways to serve customers. Device companies now are pushing into services, such as disease management, and angling to compete more aggressively on pricing.